[EN] TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKIN'S LYMPHOMAS<br/>[FR] TRAITEMENT DE TUMEURS SOLIDES RÉCIDIVANTES ET/OU RÉFRACTAIRES ET DE LYMPHOMES NON HODGKINIENS.
申请人:CELGENE CORP
公开号:WO2018031658A1
公开(公告)日:2018-02-15
Methods are provided for the treatment of relapsed and/or refractory solid tumors (including neuroendocrine carcinomas (NEC) and non-Hodgkin's lymphomas (NHLs) and the like, using substituted heterocyclic derivative compounds and pharmaceutical compositions comprising compounds useful for the inhibition of lysine specific demethylase-1 (LSD-1).
提供了一种治疗复发和/或难治性实体肿瘤(包括神经内分泌癌(NEC)和非霍奇金淋巴瘤(NHL)等)的方法,使用替代杂环衍生物化合物和包含用于抑制赖氨酸特异性去甲基化酶-1(LSD-1)的化合物的药物组合物。